Progress of research on molecular targeted therapies for colorectal cancer

Colorectal cancer (CRC) is one of the most common malignancies, accounting for approximately 10% of global cancer incidence and mortality. Approximately 20% of patients with CRC present metastatic disease (mCRC) at the time of diagnosis. Moreover, up to 50% of patients with localized disease eventua...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shilin, Ye, Jiazhou, Gao, Xing, Huang, Xi, Huang, Julu, Lu, Lu, Lu, Cheng, Li, Yongqiang, Luo, Min, Xie, Mingzhi, Lin, Yan, Liang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443711/
https://www.ncbi.nlm.nih.gov/pubmed/37614311
http://dx.doi.org/10.3389/fphar.2023.1160949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443711/
https://www.ncbi.nlm.nih.gov/pubmed/37614311
http://dx.doi.org/10.3389/fphar.2023.1160949

Ejemplares similares